Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1954662

Cover Image

PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1954662

Peptide Synthesis Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034

PUBLISHED:
PAGES: 220 Pages
DELIVERY TIME: Inquiry
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4850
Unprintable PDF & Excel (Multi User License)
USD 5850
PDF, Excel & PPT (Enterprise License)
USD 6850

Add to Cart

Growth Factors of peptide synthesis Market

The global peptide synthesis market was valued at USD 746.7 million in 2025 and is projected to grow to USD 800.16 million in 2026. The market is further expected to reach USD 1,640.52 million by 2034, registering a strong CAGR of 9.39% during the forecast period.

North America dominated the global peptide synthesis market with a 48.59% market share in 2025. Growth is driven by rising demand for peptide-based therapeutics, technological advancements in synthesis techniques, and expanding research & development investments.

Peptide synthesis involves the chemical or biological construction of short amino acid chains in a defined sequence. Modern techniques such as solid-phase peptide synthesis (SPPS) and liquid-phase peptide synthesis (LPPS) enable customized peptide production for therapeutic, diagnostic, and research applications.

Market Dynamics

Market Drivers

Rising Demand for Peptide-Based Drugs

One of the primary growth drivers is the increasing adoption of peptide-based drugs due to their high specificity, low toxicity, and improved safety profiles compared to small-molecule drugs. Peptides are widely used in oncology, metabolic disorders, diabetes, and rare diseases.

For instance, in August 2025, BioMed X collaborated with Novo Nordisk to develop oral formulations for peptide drugs such as GLP-1 receptor agonists. The growing pipeline of peptide therapeutics in clinical trials is significantly driving synthesis demand.

Market Restraints

Technical Limitations in Large-Scale Production

Despite strong growth, large-scale peptide synthesis faces challenges including incomplete coupling, aggregation, racemization, and high solvent consumption. Scaling SPPS from laboratory to commercial production often results in increased purification costs and reduced yields, limiting broader market expansion.

Market Opportunities

Technological Advancements in Synthesis Methods

Innovations such as microwave-assisted SPPS, hybrid SPPS-LPPS techniques, and continuous-flow synthesis are transforming peptide production efficiency. These advancements reduce solvent usage, shorten cycle times, and improve yield and purity.

For example, in April 2022, CEM Corporation launched the Liberty Blue 2.0 microwave peptide synthesizer, reducing solvent use by over 90% and enabling greener production processes.

Market Challenges

High Production and Purification Costs

Long and structurally complex peptides require multi-step synthesis and high-performance liquid chromatography (HPLC) purification, significantly increasing costs. For example, tirzepatide (Mounjaro), a 39-amino acid peptide drug, requires large-scale purification and complex production processes, contributing to higher manufacturing expenses.

Market Trends

Growing Outsourcing to CDMOs

A key trend in the market is the increasing outsourcing of peptide manufacturing to specialized Contract Development and Manufacturing Organizations (CDMOs). Pharmaceutical companies prefer outsourcing to reduce infrastructure investment and accelerate time-to-market.

In July 2024, Corden Pharma announced a €900 million (USD 1,047.2 million) investment to expand global peptide production capacity, highlighting growing outsourcing demand.

Segmentation Analysis

By Offering

The market is divided into products and services.

The services segment dominated the market with a 71.03% share in 2026, driven by increased outsourcing and rising demand for large-scale peptide manufacturing. In October 2025, Cambrex Corporation announced a USD 120 million investment to expand peptide manufacturing capacity in the U.S.

By Method

The market includes:

  • Solid-Phase Peptide Synthesis (SPPS)
  • Liquid-Phase Peptide Synthesis (LPPS)
  • Others

The SPPS segment dominated with a 74.42% share in 2026, owing to automation compatibility, scalability, and high efficiency. The LPPS segment is expected to grow at a CAGR of 6.45% during the forecast period.

By Application

Applications include:

  • Therapeutics
  • Diagnostics
  • Research & Development

The therapeutics segment held the largest share at 66.25% in 2026, driven by increasing commercialization of peptide drugs and a strong clinical pipeline. Diagnostics is projected to grow at 7.35% during the forecast period.

By End User

The market is segmented into:

  • Pharmaceutical & Biotechnology Companies
  • CROs & CDMOs
  • Academic & Research Institutes
  • Others

Pharmaceutical & biotechnology companies dominated with a 57.1% share in 2025 and 56.94% in 2026, supported by active therapeutic innovation and strategic collaborations. The CROs & CDMOs segment is projected to grow at a CAGR of 11.62%.

Regional Outlook

North America

North America led the market with a valuation of USD 362.84 million in 2025 and is projected to reach USD 389.08 million in 2026. The U.S. market alone is expected to reach USD 360.76 million by 2026, driven by strong biopharmaceutical R&D and strategic collaborations.

Europe

Europe is projected to grow at a CAGR of 8.72% and recorded USD 160.1 million in 2025. France recorded USD 24.1 million in 2025, while the UK and Germany are projected to reach USD 39.74 million and USD 35.84 million respectively by 2026.

Asia Pacific

Asia Pacific reached USD 140.4 million in 2025. By 2026, Japan is projected to reach USD 49.53 million, China USD 30.01 million, and India USD 29.26 million.

Latin America & Middle East & Africa

Latin America recorded USD 35.0 million in 2025, while GCC countries reached USD 18.4 million in 2025. Growth in these regions is supported by expanding R&D activities.

Competitive Landscape

The market is semi-consolidated with key players including:

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Agilent Technologies Inc.
  • Bachem AG
  • PolyPeptide Group
  • Danaher

Strategic collaborations and technology upgrades strengthen competitive positioning. For instance, in May 2025, PeptiSystems partnered with Asahi Kasei Bioprocess America to enhance peptide synthesis technologies.

Conclusion

The global peptide synthesis market, valued at USD 746.7 million in 2025, is projected to grow to USD 800.16 million in 2026 and reach USD 1,640.52 million by 2034, expanding at a CAGR of 9.39%. Growth is primarily driven by rising demand for peptide-based therapeutics, technological advancements in SPPS and LPPS, and increasing outsourcing to CDMOs. Although high production costs and large-scale synthesis challenges remain, expanding R&D investments and innovative synthesis platforms are expected to sustain strong market growth through 2034.

Segmentation By Offering, Method, Application, End User, and Region

By Offering * Products

    • Instruments
      • Peptide Synthesizers
      • Lyophilizers
      • Chromatography Systems
      • Others
    • Reagents & Consumables
  • Services
    • Custom Research-Grade Peptide Synthesis
    • Peptide Library Synthesis
    • Others

By Method * Liquid-Phase Peptide Synthesis

  • Solid-Phase Peptide Synthesis
  • Others

By Application * Therapeutics

  • Diagnostics
  • Research & Development

By End User * Pharmaceutical & Biotechnology Companies

  • CROs & CDMOs
  • Academic & Research Institutes
  • Others

By Region * North America (By Offering, Method, Application, End User, and Country)

    • U.S.
    • Canada
  • Europe (By Offering, Method, Application, End User, and Country/Sub-region)
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Offering, Method, Application, End User, and Country/Sub-region)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Offering, Method, Application, End User, and Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Offering, Method, Application, End User, and Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa
Product Code: FBI114373

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Technological Advancements in Peptide Synthesis
  • 4.2. Regulatory Scenario, By Key Countries/Regions
  • 4.3. Key Industry Developments (Mergers, Acquisitions, and Collaborations etc.)
  • 4.4. New Product Launches, By Key Players

5. Global Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Offering
    • 5.1.1. Products
      • 5.1.1.1. Instruments
        • 5.1.1.1.1. Peptide Synthesizers
        • 5.1.1.1.2. Lyophilizers
        • 5.1.1.1.3. Chromatography Systems
        • 5.1.1.1.4. Others
      • 5.1.1.2. Reagents & Consumables
    • 5.1.2. Services
      • 5.1.2.1. Custom Research-Grade Peptide Synthesis
      • 5.1.2.2. Peptide Library Synthesis
      • 5.1.2.3. Others
  • 5.2. Market Analysis, Insights and Forecast - By Method
    • 5.2.1. Liquid-Phase Peptide Synthesis
    • 5.2.2. Solid-Phase Peptide Synthesis
    • 5.2.3. Others
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Therapeutics
    • 5.3.2. Diagnostics
    • 5.3.3. Research & Development
  • 5.4. Market Analysis, Insights and Forecast - By End User
    • 5.4.1. Pharmaceutical & Biotechnology Companies
    • 5.4.2. CROs & CDMOs
    • 5.4.3. Academic & Research Institutes
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Offering
    • 6.1.1. Products
      • 6.1.1.1. Instruments
        • 6.1.1.1.1. Peptide Synthesizers
        • 6.1.1.1.2. Lyophilizers
        • 6.1.1.1.3. Chromatography Systems
        • 6.1.1.1.4. Others
      • 6.1.1.2. Reagents & Consumables
    • 6.1.2. Services
      • 6.1.2.1. Custom Research-Grade Peptide Synthesis
      • 6.1.2.2. Peptide Library Synthesis
      • 6.1.2.3. Others
  • 6.2. Market Analysis, Insights and Forecast - By Method
    • 6.2.1. Liquid-Phase Peptide Synthesis
    • 6.2.2. Solid-Phase Peptide Synthesis
    • 6.2.3. Others
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Therapeutics
    • 6.3.2. Diagnostics
    • 6.3.3. Research & Development
  • 6.4. Market Analysis, Insights and Forecast - By End User
    • 6.4.1. Pharmaceutical & Biotechnology Companies
    • 6.4.2. CROs & CDMOs
    • 6.4.3. Academic & Research Institutes
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Offering
    • 7.1.1. Products
      • 7.1.1.1. Instruments
        • 7.1.1.1.1. Peptide Synthesizers
        • 7.1.1.1.2. Lyophilizers
        • 7.1.1.1.3. Chromatography Systems
        • 7.1.1.1.4. Others
      • 7.1.1.2. Reagents & Consumables
    • 7.1.2. Services
      • 7.1.2.1. Custom Research-Grade Peptide Synthesis
      • 7.1.2.2. Peptide Library Synthesis
      • 7.1.2.3. Others
  • 7.2. Market Analysis, Insights and Forecast - By Method
    • 7.2.1. Liquid-Phase Peptide Synthesis
    • 7.2.2. Solid-Phase Peptide Synthesis
    • 7.2.3. Others
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Therapeutics
    • 7.3.2. Diagnostics
    • 7.3.3. Research & Development
  • 7.4. Market Analysis, Insights and Forecast - By End User
    • 7.4.1. Pharmaceutical & Biotechnology Companies
    • 7.4.2. CROs & CDMOs
    • 7.4.3. Academic & Research Institutes
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Spain
    • 7.5.5. Italy
    • 7.5.6. Scandinavia
    • 7.5.7. Rest of Europe

8. Asia Pacific Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Offering
    • 8.1.1. Products
      • 8.1.1.1. Instruments
        • 8.1.1.1.1. Peptide Synthesizers
        • 8.1.1.1.2. Lyophilizers
        • 8.1.1.1.3. Chromatography Systems
        • 8.1.1.1.4. Others
      • 8.1.1.2. Reagents & Consumables
    • 8.1.2. Services
      • 8.1.2.1. Custom Research-Grade Peptide Synthesis
      • 8.1.2.2. Peptide Library Synthesis
      • 8.1.2.3. Others
  • 8.2. Market Analysis, Insights and Forecast - By Method
    • 8.2.1. Liquid-Phase Peptide Synthesis
    • 8.2.2. Solid-Phase Peptide Synthesis
    • 8.2.3. Others
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Therapeutics
    • 8.3.2. Diagnostics
    • 8.3.3. Research & Development
  • 8.4. Market Analysis, Insights and Forecast - By End User
    • 8.4.1. Pharmaceutical & Biotechnology Companies
    • 8.4.2. CROs & CDMOs
    • 8.4.3. Academic & Research Institutes
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. Japan
    • 8.5.2. China
    • 8.5.3. India
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Offering
    • 9.1.1. Products
      • 9.1.1.1. Instruments
        • 9.1.1.1.1. Peptide Synthesizers
        • 9.1.1.1.2. Lyophilizers
        • 9.1.1.1.3. Chromatography Systems
        • 9.1.1.1.4. Others
      • 9.1.1.2. Reagents & Consumables
    • 9.1.2. Services
      • 9.1.2.1. Custom Research-Grade Peptide Synthesis
      • 9.1.2.2. Peptide Library Synthesis
      • 9.1.2.3. Others
  • 9.2. Market Analysis, Insights and Forecast - By Method
    • 9.2.1. Liquid-Phase Peptide Synthesis
    • 9.2.2. Solid-Phase Peptide Synthesis
    • 9.2.3. Others
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Therapeutics
    • 9.3.2. Diagnostics
    • 9.3.3. Research & Development
  • 9.4. Market Analysis, Insights and Forecast - By End User
    • 9.4.1. Pharmaceutical & Biotechnology Companies
    • 9.4.2. CROs & CDMOs
    • 9.4.3. Academic & Research Institutes
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle East & Africa Peptide Synthesis Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Offering
    • 10.1.1. Products
      • 10.1.1.1. Instruments
        • 10.1.1.1.1. Peptide Synthesizers
        • 10.1.1.1.2. Lyophilizers
        • 10.1.1.1.3. Chromatography Systems
        • 10.1.1.1.4. Others
      • 10.1.1.2. Reagents & Consumables
    • 10.1.2. Services
      • 10.1.2.1. Custom Research-Grade Peptide Synthesis
      • 10.1.2.2. Peptide Library Synthesis
      • 10.1.2.3. Others
  • 10.2. Market Analysis, Insights and Forecast - By Method
    • 10.2.1. Liquid-Phase Peptide Synthesis
    • 10.2.2. Solid-Phase Peptide Synthesis
    • 10.2.3. Others
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Therapeutics
    • 10.3.2. Diagnostics
    • 10.3.3. Research & Development
  • 10.4. Market Analysis, Insights and Forecast - By End User
    • 10.4.1. Pharmaceutical & Biotechnology Companies
    • 10.4.2. CROs & CDMOs
    • 10.4.3. Academic & Research Institutes
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles (Overview, Products & Services, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
    • 11.2.1. Thermo Fisher Scientific Inc.
    • 11.2.2. Merck KGaA
    • 11.2.3. GenScript
    • 11.2.4. Agilent Technologies Inc.
    • 11.2.5. Bachem AG
    • 11.2.6. Waters Corporation
    • 11.2.7. Danaher
    • 11.2.8. PolyPeptide Group
    • 11.2.9. Bio-Synthesis Inc.
    • 11.2.10. CordenPharma
Product Code: FBI114373

List of Tables

  • Table 1: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By Offering, 2021-2034
  • Table 2: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By Products, 2021-2034
  • Table 3: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By Instruments, 2021-2034
  • Table 4: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By Services, 2021-2034
  • Table 5: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By Method, 2021-2034
  • Table 6: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 7: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 8: Global Peptide Synthesis Market Revenue (USD Million) Forecast, By Region, 2021-2034
  • Table 9: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By Offering, 2021-2034
  • Table 10: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By Products, 2021-2034
  • Table 11: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By Instruments, 2021-2034
  • Table 12: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By Services, 2021-2034
  • Table 13: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By Method, 2021-2034
  • Table 14: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 15: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 16: North America Peptide Synthesis Market Revenue (USD Million) Forecast, By Country, 2021-2034
  • Table 17: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By Offering, 2021-2034
  • Table 18: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By Products, 2021-2034
  • Table 19: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By Instruments, 2021-2034
  • Table 20: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By Services, 2021-2034
  • Table 21: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By Method, 2021-2034
  • Table 22: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 23: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 24: Europe Peptide Synthesis Market Revenue (USD Million) Forecast, By Country/Sub-Region, 2021-2034
  • Table 25: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By Offering, 2021-2034
  • Table 26: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By Products, 2021-2034
  • Table 27: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By Instruments, 2021-2034
  • Table 28: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By Services, 2021-2034
  • Table 29: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By Method, 2021-2034
  • Table 30: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 31: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 32: Asia Pacific Peptide Synthesis Market Revenue (USD Million) Forecast, By Country/Sub-Region, 2021-2034
  • Table 33: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By Offering, 2021-2034
  • Table 34: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By Products, 2021-2034
  • Table 35: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By Instruments, 2021-2034
  • Table 36: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By Services, 2021-2034
  • Table 37: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By Method, 2021-2034
  • Table 38: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 39: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 40: Latin America Peptide Synthesis Market Revenue (USD Million) Forecast, By Country/Sub-Region, 2021-2034
  • Table 41: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By Offering, 2021-2034
  • Table 42: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By Products, 2021-2034
  • Table 43: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By Instruments, 2021-2034
  • Table 44: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By Services, 2021-2034
  • Table 45: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By Method, 2021-2034
  • Table 46: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By Application, 2021-2034
  • Table 47: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By End User, 2021-2034
  • Table 48: Middle East & Africa Peptide Synthesis Market Revenue (USD Million) Forecast, By Country/Sub-Region, 2021-2034

List of Figures

  • Figure 1: Global Peptide Synthesis Market Revenue Breakdown (USD Million, %) By Region, 2025 & 2034
  • Figure 2: Global Peptide Synthesis Market Value Share (%), By Offering, 2025 & 2034
  • Figure 3: Global Peptide Synthesis Market Value Share (%), By Method, 2025 & 2034
  • Figure 4: Global Peptide Synthesis Market Value Share (%), By Application, 2025 & 2034
  • Figure 5: Global Peptide Synthesis Market Value Share (%), By End User, 2025 & 2034
  • Figure 6: Global Peptide Synthesis Market Value (USD Million), By Region, 2025 & 2034
  • Figure 7: North America Peptide Synthesis Market Value (USD Million), By Offering, 2025 & 2034
  • Figure 8: North America Peptide Synthesis Market Value Share (%), By Offering, 2025
  • Figure 9: North America Peptide Synthesis Market Value (USD Million), By Method, 2025 & 2034
  • Figure 10: North America Peptide Synthesis Market Value Share (%), By Method, 2025
  • Figure 11: North America Peptide Synthesis Market Value (USD Million), By Application, 2025 & 2034
  • Figure 12: North America Peptide Synthesis Market Value Share (%), By Application, 2025
  • Figure 13: North America Peptide Synthesis Market Value (USD Million), By End User, 2025 & 2034
  • Figure 14: North America Peptide Synthesis Market Value Share (%), By End User, 2025
  • Figure 15: North America Peptide Synthesis Market Value (USD Million), By Country, 2025 & 2034
  • Figure 16: North America Peptide Synthesis Market Value Share (%), By Country, 2025
  • Figure 17: Europe Peptide Synthesis Market Value (USD Million), By Offering, 2025 & 2034
  • Figure 18: Europe Peptide Synthesis Market Value Share (%), By Offering, 2025
  • Figure 19: Europe Peptide Synthesis Market Value (USD Million), By Method, 2025 & 2034
  • Figure 20: Europe Peptide Synthesis Market Value Share (%), By Method, 2025
  • Figure 21: Europe Peptide Synthesis Market Value (USD Million), By Application, 2025 & 2034
  • Figure 22: Europe Peptide Synthesis Market Value Share (%), By Application, 2025
  • Figure 23: Europe Peptide Synthesis Market Value (USD Million), By End User, 2025 & 2034
  • Figure 24: Europe Peptide Synthesis Market Value Share (%), By End User, 2025
  • Figure 25: Europe Peptide Synthesis Market Value (USD Million), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Peptide Synthesis Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Peptide Synthesis Market Value (USD Million), By Offering, 2025 & 2034
  • Figure 28: Asia Pacific Peptide Synthesis Market Value Share (%), By Offering, 2025
  • Figure 29: Asia Pacific Peptide Synthesis Market Value (USD Million), By Method, 2025 & 2034
  • Figure 30: Asia Pacific Peptide Synthesis Market Value Share (%), By Method, 2025
  • Figure 31: Asia Pacific Peptide Synthesis Market Value (USD Million), By Application, 2025 & 2034
  • Figure 32: Asia Pacific Peptide Synthesis Market Value Share (%), By Application, 2025
  • Figure 33: Asia Pacific Peptide Synthesis Market Value (USD Million), By End User, 2025 & 2034
  • Figure 34: Asia Pacific Peptide Synthesis Market Value Share (%), By End User, 2025
  • Figure 35: Asia Pacific Peptide Synthesis Market Value (USD Million), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Peptide Synthesis Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Peptide Synthesis Market Value (USD Million), By Offering, 2025 & 2034
  • Figure 38: Latin America Peptide Synthesis Market Value Share (%), By Offering, 2025
  • Figure 39: Latin America Peptide Synthesis Market Value (USD Million), By Method, 2025 & 2034
  • Figure 40: Latin America Peptide Synthesis Market Value Share (%), By Method, 2025
  • Figure 41: Latin America Peptide Synthesis Market Value (USD Million), By Application, 2025 & 2034
  • Figure 42: Latin America Peptide Synthesis Market Value Share (%), By Application, 2025
  • Figure 43: Latin America Peptide Synthesis Market Value (USD Million), By End User, 2025 & 2034
  • Figure 44: Latin America Peptide Synthesis Market Value Share (%), By End User, 2025
  • Figure 45: Latin America Peptide Synthesis Market Value (USD Million), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Peptide Synthesis Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Peptide Synthesis Market Value (USD Million), By Offering, 2025 & 2034
  • Figure 48: Middle East & Africa Peptide Synthesis Market Value Share (%), By Offering, 2025
  • Figure 49: Middle East & Africa Peptide Synthesis Market Value (USD Million), By Method, 2025 & 2034
  • Figure 50: Middle East & Africa Peptide Synthesis Market Value Share (%), By Method, 2025
  • Figure 51: Middle East & Africa Peptide Synthesis Market Value (USD Million), By Application, 2025 & 2034
  • Figure 52: Middle East & Africa Peptide Synthesis Market Value Share (%), By Application, 2025
  • Figure 53: Middle East & Africa Peptide Synthesis Market Value (USD Million), By End User, 2025 & 2034
  • Figure 54: Middle East & Africa Peptide Synthesis Market Value Share (%), By End User, 2025
  • Figure 55: Middle East & Africa Peptide Synthesis Market Value (USD Million), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Peptide Synthesis Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Peptide Synthesis Market Share (%), By Company, 2025
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!